Dr Reddys Laboratories (RDY) Intangibles (2009 - 2026)

Dr Reddys Laboratories (RDY) has reported Intangibles for 10 consecutive years, with $1.1 billion the latest figure, recorded in Q1 2026.

• Quarterly Intangibles fell 1.23% year-over-year to $1.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 billion (down 1.23% YoY) and the FY2026 annual result came in at $1.1 billion, down 1.23% from the prior year.
• Intangibles retreated to $1.1 billion in Q1 2026 per RDY's latest filing, from $1.1 billion in the prior quarter.
• Over the last five years, Intangibles for RDY reached as high as $1.1 billion in Q1 2025 and fell as low as $359.0 million in Q1 2022.
• A 5-year average of $686.2 million and a median of $443.0 million in 2024 frame the typical range for Intangibles.
• Annual changes were most pronounced in 2022 — Intangibles dropped 26.28% — and 2025, when it soared 155.98%.
• Year by year, Intangibles stood at $359.0 million in 2022, then increased by 4.46% to $375.0 million in 2023, then rose by 18.13% to $443.0 million in 2024, then surged by 155.98% to $1.1 billion in 2025, then fell by 1.23% to $1.1 billion in 2026.
• According to Business Quant data, Intangibles over the past three periods registered $1.1 billion, $1.1 billion, and $443.0 million for Q1 2026, Q1 2025, and Q1 2024 respectively.